sevoflurane and Liver Dysfunction
sevoflurane has been researched along with Liver Dysfunction in 19 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" Previous studies have demonstrated that sevoflurane, a volatile anesthetic, can preserve the endothelial glycocalyx in heart tissues against ischemia-reperfusion injury." | 7.83 | Protective effects of sevoflurane in hepatic ischemia-reperfusion injury. ( Li, J; Liu, HQ; Lv, GY; Yuan, T; Zhao, X, 2016) |
"After approval by the institutional animal care and use committee, 36 Japanese White rabbits underwent partial hepatic ischemia for 90 min either under sevoflurane or propofol anesthesia." | 3.88 | Interaction between anesthetic conditioning and ischemic preconditioning on metabolic function after hepatic ischemia-reperfusion in rabbits. ( Kosugi, S; Kotake, Y; Morisaki, H; Nagata, H; Suzuki, T; Yamada, T, 2018) |
"The study shows that sevoflurane postconditioning affects apoptosis of hepatocytes after ischemia-reperfusion injury in patients." | 3.88 | Sevoflurane Protects Hepatocytes From Ischemic Injury by Reducing Reactive Oxygen Species Signaling of Hepatic Stellate Cells: Translational Findings Based on a Clinical Trial. ( Beck-Schimmer, B; Booy, C; Köppel, S; Roth Z'graggen, B; Schadde, E; Schläpfer, M; Spahn, DR, 2018) |
" Previous studies have demonstrated that sevoflurane, a volatile anesthetic, can preserve the endothelial glycocalyx in heart tissues against ischemia-reperfusion injury." | 3.83 | Protective effects of sevoflurane in hepatic ischemia-reperfusion injury. ( Li, J; Liu, HQ; Lv, GY; Yuan, T; Zhao, X, 2016) |
"The liver of all rats given halothane (14% O(2)) had extensive centrilobular necrosis and denaturation." | 3.73 | Ca2+ cytochemical changes of hepatotoxicity caused by halothane and sevoflurane in enzyme-induced hypoxic rats. ( Li, Q; Liu, ZQ; Yang, LQ; Yu, WF; Zhou, MT, 2005) |
"Hepatic ischemia-reperfusion injury has a significant impact on liver resection and transplantation." | 1.40 | Ischemic versus pharmacologic hepatic preconditioning. ( Azambuja, G; Balzan, SM; de Souza, PL; Gava, VG; Horta, JA; Pra, D; Rieger, A; Schopf, L; Trombini, L; Zenkner, FF, 2014) |
Research
Studies (19)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 8 (42.11) | 24.3611 |
2020's | 5 (26.32) | 2.80 |
Authors
Authors | Studies |
---|---|
Jester, N | 1 |
Kang, P | 1 |
Steele, M | 1 |
Howells, L | 1 |
Santer, M | 1 |
Sivyer, K | 1 |
Lawton, S | 1 |
Roberts, A | 1 |
Teasdale, E | 1 |
Muller, I | 1 |
Greenwell, K | 1 |
Silva, LP | 1 |
Silva, TA | 1 |
Moraes, FC | 1 |
Fatibello-Filho, O | 1 |
Durrani, TS | 1 |
Farooqi, A | 1 |
Zhang, J | 3 |
Xu, C | 1 |
Gao, L | 1 |
Zhang, D | 1 |
Li, C | 1 |
Liu, J | 1 |
Jiang, PP | 1 |
Guo, YX | 1 |
Yang, XL | 1 |
Xu, J | 1 |
Wang, D | 1 |
Liu, P | 1 |
Zhong, L | 1 |
Huang, S | 1 |
Gong, L | 1 |
Han, D | 1 |
Wang, S | 1 |
Xiao, M | 1 |
Meng, Y | 1 |
Kraemer, R | 1 |
Smith, HJ | 1 |
Matthys, H | 1 |
Xin, D | 1 |
Bai, Y | 1 |
Bi, Y | 1 |
He, L | 1 |
Kang, Y | 1 |
Pan, C | 1 |
Zhu, H | 1 |
Chen, H | 1 |
Qu, L | 1 |
Lan, X | 1 |
Tong, Y | 1 |
Wang, L | 1 |
Wang, Q | 1 |
Huang, H | 1 |
Chen, X | 1 |
Zhang, Q | 1 |
Li, H | 3 |
Sun, N | 1 |
Liu, G | 1 |
Zhang, B | 1 |
Song, F | 1 |
Alterovitz, G | 1 |
Dai, H | 1 |
Zhang, L | 1 |
Ji, H | 1 |
Zhang, H | 1 |
Cheng, Z | 1 |
Benoit, L | 1 |
Dieu, A | 1 |
Foguenne, M | 1 |
Bonaccorsi-Riani, E | 1 |
Ma, H | 1 |
Yang, B | 1 |
Yu, L | 1 |
Gao, Y | 1 |
Ye, X | 1 |
Liu, Y | 1 |
Li, Z | 1 |
Li, E | 1 |
Xiao, X | 1 |
Liu, D | 1 |
Chen, S | 1 |
Li, X | 1 |
Ge, M | 1 |
Huang, W | 1 |
Yamada, T | 1 |
Nagata, H | 1 |
Kosugi, S | 1 |
Suzuki, T | 1 |
Morisaki, H | 1 |
Kotake, Y | 1 |
Beck-Schimmer, B | 3 |
Roth Z'graggen, B | 1 |
Booy, C | 1 |
Köppel, S | 1 |
Spahn, DR | 2 |
Schläpfer, M | 1 |
Schadde, E | 1 |
Nguyen, TM | 1 |
Fleyfel, M | 1 |
Boleslawski, E | 1 |
M'Ba, L | 1 |
Geniez, M | 1 |
Ethgen, S | 1 |
Béhal, H | 1 |
Lebuffe, G | 1 |
Balzan, SM | 1 |
Gava, VG | 1 |
Rieger, A | 1 |
Pra, D | 1 |
Trombini, L | 1 |
Zenkner, FF | 1 |
Horta, JA | 1 |
Azambuja, G | 1 |
Schopf, L | 1 |
de Souza, PL | 1 |
Li, J | 1 |
Yuan, T | 1 |
Zhao, X | 1 |
Lv, GY | 1 |
Liu, HQ | 1 |
Granja, TF | 1 |
Köhler, D | 1 |
Schad, J | 1 |
de Oliveira, CB | 1 |
Konrad, F | 1 |
Hoch-Gutbrod, M | 1 |
Streienberger, A | 1 |
Rosenberger, P | 1 |
Straub, A | 1 |
Eichler, K | 1 |
Urner, M | 1 |
Twerenbold, C | 1 |
Kern, S | 1 |
Brügger, U | 1 |
Ganter, MT | 1 |
Slankamenac, K | 1 |
Breitenstein, S | 1 |
Graf, R | 1 |
Puhan, MA | 1 |
Clavien, PA | 1 |
Yu, WF | 1 |
Yang, LQ | 1 |
Zhou, MT | 1 |
Liu, ZQ | 1 |
Li, Q | 1 |
Lorsomradee, S | 2 |
Cromheecke, S | 1 |
De Hert, SG | 1 |
Fukuda, H | 1 |
Saitoh, K | 1 |
Saitoh, J | 1 |
Hirabayashi, Y | 1 |
Mitsuhata, H | 1 |
Kasuda, H | 1 |
Shimizu, R | 1 |
Bito, H | 1 |
Ikeda, K | 1 |
Eger, EI | 1 |
Gong, D | 1 |
Koblin, DD | 1 |
Bowland, T | 1 |
Ionescu, P | 1 |
Laster, MJ | 1 |
Weiskopf, RB | 1 |
Shichinohe, Y | 1 |
Masuda, Y | 1 |
Takahashi, H | 1 |
Kotaki, M | 1 |
Omote, T | 1 |
Shichinohe, M | 1 |
Namiki, A | 1 |
Reviews
2 reviews available for sevoflurane and Liver Dysfunction
Article | Year |
---|---|
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Antifungal Agents; Antirheumatic | 2021 |
Experimental and Clinical Aspects of Sevoflurane Preconditioning and Postconditioning to Alleviate Hepatic Ischemia-Reperfusion Injury: A Scoping Review.
Topics: Humans; Ischemia; Liver Diseases; Reperfusion Injury; Sevoflurane | 2023 |
Trials
4 trials available for sevoflurane and Liver Dysfunction
Article | Year |
---|---|
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Antifungal Agents; Antirheumatic | 2021 |
Economic Evaluation of Pharmacologic Pre- and Postconditioning With Sevoflurane Compared With Total Intravenous Anesthesia in Liver Surgery: A Cost Analysis.
Topics: Adult; Aged; Anesthesia, Intravenous; Cost-Benefit Analysis; Female; Humans; Length of Stay; Liver D | 2017 |
Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery.
Topics: Administration, Inhalation; Aged; Alanine Transaminase; Anesthesia, General; Anesthetics, Inhalation | 2006 |
Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia.
Topics: Adult; Aged; Alanine Transaminase; Anesthesia, General; Anesthetics, Inhalation; Aspartate Aminotran | 1996 |
Other Studies
14 other studies available for sevoflurane and Liver Dysfunction
Article | Year |
---|---|
Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Ischemia; Liver; Liver Diseases; Male; Mic | 2022 |
Sevoflurane protects the liver from ischemia-reperfusion injury by regulating Nrf2/HO-1 pathway.
Topics: Animals; Apoptosis; Cell Line; Disease Models, Animal; Heme Oxygenase (Decyclizing); Heme Oxygenase- | 2021 |
Sevoflurane preconditioning activates HGF/Met-mediated autophagy to attenuate hepatic ischemia-reperfusion injury in mice.
Topics: Animals; Apoptosis; Hepatocyte Growth Factor; Hepatocytes; Liver Diseases; Male; Mice; Mice, Inbred | 2021 |
Interaction between anesthetic conditioning and ischemic preconditioning on metabolic function after hepatic ischemia-reperfusion in rabbits.
Topics: Anesthesia; Anesthetics, Inhalation; Animals; Disease Models, Animal; Hemodynamics; Ischemic Precond | 2018 |
Sevoflurane Protects Hepatocytes From Ischemic Injury by Reducing Reactive Oxygen Species Signaling of Hepatic Stellate Cells: Translational Findings Based on a Clinical Trial.
Topics: Antioxidants; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Culture Media, Conditioned; C | 2018 |
Effect of pharmacological preconditioning with sevoflurane during hepatectomy with intermittent portal triad clamping.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Constriction; Female; Hepatectomy; Humans; | 2019 |
Ischemic versus pharmacologic hepatic preconditioning.
Topics: Anesthetics, Inhalation; Animals; Bilirubin; Biomarkers; C-Reactive Protein; DNA Damage; Ischemic Pr | 2014 |
Protective effects of sevoflurane in hepatic ischemia-reperfusion injury.
Topics: Alanine Transaminase; Anesthetics, Inhalation; Animals; Aspartate Aminotransferases; Endothelium; Fe | 2016 |
Adenosine Receptor Adora2b Plays a Mechanistic Role in the Protective Effect of the Volatile Anesthetic Sevoflurane during Liver Ischemia/Reperfusion.
Topics: Adult; Anesthetics, Inhalation; Animals; Disease Models, Animal; Humans; Liver; Liver Diseases; Meth | 2016 |
Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery?
Topics: Administration, Inhalation; Adult; Aged; Alanine Transaminase; Anesthetics, Inhalation; Anesthetics, | 2012 |
Ca2+ cytochemical changes of hepatotoxicity caused by halothane and sevoflurane in enzyme-induced hypoxic rats.
Topics: Alanine Transaminase; Anesthetics, Inhalation; Animals; Calcium; Chemical and Drug Induced Liver Inj | 2005 |
[Changes in plasma concentrations of human hepatocyte growth factor before and after major intra-abdominal surgery under nitrous oxide-sevoflurane anesthesia].
Topics: Abdomen; Aged; Aged, 80 and over; Anesthesia, Inhalation; Ethers; Female; Hepatocyte Growth Factor; | 1994 |
Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
Topics: Adult; Anesthesia, General; Anesthetics, Inhalation; Biomarkers; Chemical and Drug Induced Liver Inj | 1997 |
[A case of postoperative hepatic injury after sevoflurane anesthesia].
Topics: Anesthesia, Inhalation; Anesthetics; Cross Reactions; Enflurane; Ethers; Humans; Liver Diseases; Mal | 1992 |